am 251 has been researched along with Hodgkin Disease in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, AH | 1 |
| Renné, C | 1 |
| Maronde, E | 1 |
| Koch, M | 1 |
| Grabiec, U | 1 |
| Kallendrusch, S | 1 |
| Rengstl, B | 1 |
| Newrzela, S | 1 |
| Hartmann, S | 1 |
| Hansmann, ML | 1 |
| Dehghani, F | 1 |
1 other study available for am 251 and Hodgkin Disease
| Article | Year |
|---|---|
Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma.
Topics: Apoptosis; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hodgkin Disease; Humans; Piperi | 2013 |